论文部分内容阅读
微囊化基因工程细胞移植技术是一种新的生物活性物质投递方式,能够在不用免疫抑制剂的情况下移植动物源性的细胞和组织。该技术已在多种肿瘤的治疗中显示出良好的应用前景,现对其进展及在恶性肿瘤研究中的应用作一综述。
Microencapsulated genetically engineered cell transplantation is a novel biologically active substance delivery method that allows the transplantation of animal-derived cells and tissues without the use of immunosuppressive agents. The technology has shown a good prospect in the treatment of a variety of tumors, and its progress and application in the study of malignant tumors are reviewed.